846

THE SAFETY AND TECHNICAL FEASIBILITY OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER AMONG PATIENTS ≥75 YEARS OF AGE – A SYSTEMATIC REVIEW AND META-ANALYSIS

Date
May 20, 2024

Introduction
There is a lack of consensus on the safety and efficacy of endoscopic submucosal dissection (ESD) for the treatment of early gastric cancer among elderly patients.
Methods
A systematic review to identify the impact of ESD on individuals aged ≥75 years was performed. A meta-analysis of safety and efficacy-related outcomes was performed to compute a risk ratio (RR) with their corresponding 95% confidence intervals. Influence analyses were done to assess the robustness of our findings. Certainty was assessed using the GRADE approach.
Results
We included 15 studies, with a mean age difference of 17.85 years between elderly and control arms. Elderly patients had larger lesions (mean 1.77 mm; 1.13, 2.40 mm) compared to control. On subgroup analysis, the difference in lesion size was significant only for patients ≥80 years of age and controls (mean 2.66 mm; 0.83, 4.50 mm). No significant disparities were observed in procedure time or length of stay (LOS) for elderly and control arms, regardless of age group.
Procedural efficacy, assessed by en bloc and complete resection rates, did not differ significantly between elderly and control arms. However, Elderly patients had a higher risk of adverse events (RR: 1.26; 1.11, 1.42; I2 0%; CERTAINTY: LOW). Subgroup analysis revealed higher risk for patients ≥75 years (RR: 1.23; 1.03, 1.48; I2 0%; CERTAINTY: LOW) and ≥80 years (RR: 1.27; 1.07, 1.51; I2 0%; CERTAINTY: LOW), but not for patients 65-75 years compared to controls. The risk of post-procedural bleeding was higher in elderly patients (RR: 1.20; 1.03, 1.40; I2 0% CERTAINTY: LOW) and significantly higher for patients ≥80 years (RR: 1.28; 1.04, 1.57; I2 0%; CERTAINTY: LOW), but not for patients ≥75 years or 65-75 years compared to controls.
The risk of post-operative pneumonia was higher in elderly patients (RR: 3.36; 1.87, 6.05; I2 6.2%; CERTAINTY: MODERATE). Subgroup analysis showed significantly higher risk for patients ≥75 years (RR: 4.16; 2.20, 7.87; I2 0%; CERTAINTY: MODERATE), with continued significance on influence analysis. Patients ≥80 years did not exhibit a higher risk, but influence analysis revealed significance with the removal of one study (RR: 12.10; 1.79, 81.75). Patients 65-75 years did not have a higher risk of post-operative pneumonia compared to controls.
No significant difference in luminal perforation rate was observed between elderly and control arms in pooled or subgroup analyses Data on procedural mortality was insufficient to perform a meta-analysis.
Conclusion
In patients ≥75 years of age, ESD for early gastric cancer increased the risk of post-operative pneumonia compared to their younger counterparts based on moderate certainty evidence. These findings warrant further study of the risk factors for development of pulmonary events and pneumonia after gastric ESD to allow better patient selection and preventive efforts.

Speakers

Speaker Image for Nirav Thosani
The University of Texas Health Science Center at Houston John P and Katherine G McGovern Medical School

Tracks

Related Products

Thumbnail for GREEN ENDOSCOPY INITIATIVE: AN EFFORT TO REDUCE ENDOSCOPIC WASTE DURING COLONOSCOPIES IN A LARGE TERTIARY CARE INSTITUTE
GREEN ENDOSCOPY INITIATIVE: AN EFFORT TO REDUCE ENDOSCOPIC WASTE DURING COLONOSCOPIES IN A LARGE TERTIARY CARE INSTITUTE
The healthcare sector generates 8.5% of greenhouse emissions in the United States, about 70-80% of which is from used instruments and supplies. GI endoscopy is the third largest contributor to healthcare-related waste with CO2 emission over 85,000 metric tons annually…
Thumbnail for NITROUS OXIDE CRYOBALLOON ABLATION FOR ERADICATION OF NON-AMPULLARY SPORADIC AND FAMILIAL DUODENAL ADENOMAS: PRELIMINARY RESULTS OF A MULTICENTER CLINICAL TRIAL
NITROUS OXIDE CRYOBALLOON ABLATION FOR ERADICATION OF NON-AMPULLARY SPORADIC AND FAMILIAL DUODENAL ADENOMAS: PRELIMINARY RESULTS OF A MULTICENTER CLINICAL TRIAL
Endoscopic ultrasound-guided gastroejejunostomy (EUS-GJ) has gained popularity in treating malignant gastric outlet obstruction (GOO). EUS-GJ has also been used to manage benign GOO with promising technical and clinical success…
Thumbnail for ARTIFICIAL INTELLIGENCE ENHANCED ADEQUACY TESTING FOR EUS FNA SAMPLES FROM SOLID PANCREATIC LESIONS: PROSPECTIVE BLINDED TRIAL
ARTIFICIAL INTELLIGENCE ENHANCED ADEQUACY TESTING FOR EUS FNA SAMPLES FROM SOLID PANCREATIC LESIONS: PROSPECTIVE BLINDED TRIAL
Rapid on-site evaluation (ROSE) can provide immediate assurance of sample adequacy; however, significant manpower and logistic challenges have affected overall utilization of ROSE during endoscopic ultrasound guided fine needle aspiration and biopsy (EUS-FNA/B)…